These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 12586771)
1. In vivo dimerization of types 1, 2, and 3 iodothyronine selenodeiodinases. Curcio-Morelli C; Gereben B; Zavacki AM; Kim BW; Huang S; Harney JW; Larsen PR; Bianco AC Endocrinology; 2003 Mar; 144(3):937-46. PubMed ID: 12586771 [TBL] [Abstract][Full Text] [Related]
2. Substitution of cysteine for a conserved alanine residue in the catalytic center of type II iodothyronine deiodinase alters interaction with reducing cofactor. Kuiper GG; Klootwijk W; Visser TJ Endocrinology; 2002 Apr; 143(4):1190-8. PubMed ID: 11897672 [TBL] [Abstract][Full Text] [Related]
3. Cellular and structural biology of the deiodinases. Bianco AC; Larsen PR Thyroid; 2005 Aug; 15(8):777-86. PubMed ID: 16131321 [TBL] [Abstract][Full Text] [Related]
4. The role of selenocysteine 133 in catalysis by the human type 2 iodothyronine deiodinase. Buettner C; Harney JW; Larsen PR Endocrinology; 2000 Dec; 141(12):4606-12. PubMed ID: 11108274 [TBL] [Abstract][Full Text] [Related]
5. Iodothyronine deiodinase structure and function: from ascidians to humans. Darras VM; Van Herck SL J Endocrinol; 2012 Nov; 215(2):189-206. PubMed ID: 22825922 [TBL] [Abstract][Full Text] [Related]
6. Expression of recombinant membrane-bound type I iodothyronine deiodinase in yeast. Kuiper GG; Klootwijk W; Visser TJ J Mol Endocrinol; 2005 Jun; 34(3):865-78. PubMed ID: 15956354 [TBL] [Abstract][Full Text] [Related]
7. Molecular biological and biochemical characterization of the human type 2 selenodeiodinase. Salvatore D; Bartha T; Harney JW; Larsen PR Endocrinology; 1996 Aug; 137(8):3308-15. PubMed ID: 8754756 [TBL] [Abstract][Full Text] [Related]
12. Expression of chicken hepatic type I and type III iodothyronine deiodinases during embryonic development. Van der Geyten S; Sanders JP; Kaptein E; Darras VM; Kühn ER; Leonard JL; Visser TJ Endocrinology; 1997 Dec; 138(12):5144-52. PubMed ID: 9389494 [TBL] [Abstract][Full Text] [Related]
13. Substitution of serine for proline in the active center of type 2 iodothyronine deiodinase substantially alters its in vitro biochemical properties with dithiothreitol but not its function in intact cells. Goemann IM; Gereben B; Harney JW; Zhu B; Maia AL; Larsen PR Endocrinology; 2010 Feb; 151(2):821-9. PubMed ID: 19966180 [TBL] [Abstract][Full Text] [Related]
14. Expression profiles of the three iodothyronine deiodinases, D1, D2, and D3, in the developing rat. Bates JM; St Germain DL; Galton VA Endocrinology; 1999 Feb; 140(2):844-51. PubMed ID: 9927314 [TBL] [Abstract][Full Text] [Related]
15. Substrate-induced down-regulation of human type 2 deiodinase (hD2) is mediated through proteasomal degradation and requires interaction with the enzyme's active center. Steinsapir J; Bianco AC; Buettner C; Harney J; Larsen PR Endocrinology; 2000 Mar; 141(3):1127-35. PubMed ID: 10698189 [TBL] [Abstract][Full Text] [Related]
16. Ontogeny of iodothyronine deiodinases in human liver. Richard K; Hume R; Kaptein E; Sanders JP; van Toor H; De Herder WW; den Hollander JC; Krenning EP; Visser TJ J Clin Endocrinol Metab; 1998 Aug; 83(8):2868-74. PubMed ID: 9709961 [TBL] [Abstract][Full Text] [Related]
17. Substitution of cysteine for selenocysteine in the catalytic center of type III iodothyronine deiodinase reduces catalytic efficiency and alters substrate preference. Kuiper GG; Klootwijk W; Visser TJ Endocrinology; 2003 Jun; 144(6):2505-13. PubMed ID: 12746313 [TBL] [Abstract][Full Text] [Related]
18. A disulfide bonding interaction role for cysteines in the extracellular domain of the thyrotropin-releasing hormone receptor. Cook JV; McGregor A; Lee T; Milligan G; Eidne KA Endocrinology; 1996 Jul; 137(7):2851-8. PubMed ID: 8770906 [TBL] [Abstract][Full Text] [Related]
19. H2O2-induced intermolecular disulfide bond formation between receptor protein-tyrosine phosphatases. van der Wijk T; Overvoorde J; den Hertog J J Biol Chem; 2004 Oct; 279(43):44355-61. PubMed ID: 15294898 [TBL] [Abstract][Full Text] [Related]
20. Substitution of cysteine for selenocysteine in type I iodothyronine deiodinase reduces the catalytic efficiency of the protein but enhances its translation. Berry MJ; Maia AL; Kieffer JD; Harney JW; Larsen PR Endocrinology; 1992 Oct; 131(4):1848-52. PubMed ID: 1396330 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]